News March 2022
Dear ISAP members!
As the situation in Europe is steadily stabilizing after the pandemic winter, we are pleased to share with you information on two upcoming events around the ECCMID meeting in April 2022:
EPASG Pre-ECCMID Course
Prior to ECCMID, on 21-22 April 2022, EPASG is hosting a on-site workshop titled "Optimised dosing of antibiotics - understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring" in Oerias (close to Lisbon), Portugal. ESCMID indicated that the course is filling up quickly. The program can be found here. Register here, if you are interested to join!
ISAP Meeting
Right after the EPASG course on 22 April 2022, and hence on the evening before ECCMID, we will hold an ISAP Scientific Meeting from 16.30 to approx. 20.00 in the same hotel (Lagoas Park, Oerias) as the EPASG course, in Oerias, Portugal. Registration is now closed.
Location (ca. 20 mins from Lisbon airport/Lisbon city centre by taxi):
Lagoas Park Hotel
Rua Encosta das Lagoas
2740-245 Porto Salvo, Portugal
Program:
16.15-16.30 Arrival and Welcome
16.30-17.15 ISAP General Meeting
17.15-19.00 Young Investigator Session
|
First name |
Last Name |
Title |
|
Aneeq |
Farooq |
Interaction screening of ceftazidime-avibactam and tigecycline against six clinical and nine isogenic E. coli and K. pneumoniae strains expressing carbapenemases |
|
Wisse |
Van Os |
Impact of individual ascitic fluids on bacterial growth and ceftriaxone effect in an in vitro model of spontaneous bacterial peritonitis |
|
Nicole |
Zimmermann |
Integrated in vitro approach to understand the exposure-effect relationship of fosfomycin against Escherichia coli |
|
Amaury |
O'Jeanson |
A model-based analysis of pharmacokinetic-pharmacodynamic (PK/PD) indices of avibactam against β-lactamase-producing Gram-negative bacteria |
|
Jinxin |
Zhao |
PhageGE: An Interactive Web-based R Shiny Application for Bacteriophage Pharmacology |
|
Sue |
Nang |
Elucidating the pharmacokinetics/ pharmacodynamics of bacteriophage therapy against Pseudomonas aeruginosa using a mouse bacteraemia model |
|
Romain |
Aubry |
Semi-mechanistic PKPD modelling of ceftazidime/avibactam and colistin combination against five multidrug resistant Klebsiella pneumoniae isolates |
|
Mathilde |
Lacroix |
In vitro PK/PD modelling of polymyxin B against resistant strain of A. baumannii in presence of mucin |
|
Matthias |
Gijsen |
Model-based TDM of vancomycin: a retrospective comparison with routine TDM-based dosing |
|
Gert-Jan |
Wijnant |
Pharmacokinetics and PK/PD of temocillin in non-ICU urinary tract infection patients with various stages of renal insufficiency |
|
Tim |
Ewoldt |
Large variability of unbound active fraction of ceftriaxone in contrast to ciprofloxacin in plasma of critically ill patients |
|
Maria |
Sanz Codina |
Relationship between pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill COVID-19 patients with documented Gram-negative superinfections treated with meropenem continuous infusion |
19.00-20.00 Reception with light food and beverages
We hope to see you in Portugal, soon!
Best regards
ISAP Council
- Created on .